Is it time to start to consider treating the liver in glutaric aciduria type 1?
Journal of Inherited Metabolic Disease · 2023
DOI: 10.1002/jimd.12623 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Inherited Metabolic Disease, 2023. Verfasst von Sander Houten und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Amino Acid Metabolism, Inborn Errors, Brain Diseases, Metabolic. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Section of Clinical Genetics and Metabolism, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Zitieren
APA
Houten, S., & Coughlin, C. R. (2023). Is it time to start to consider treating the liver in glutaric aciduria type 1?. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12623
Vancouver
Houten S, Coughlin CR. Is it time to start to consider treating the liver in glutaric aciduria type 1?. Journal of Inherited Metabolic Disease. 2023. doi:10.1002/jimd.12623
BibTeX
@article{Houten2023,
author = {Houten, Sander and Coughlin, Curtis R},
title = {Is it time to start to consider treating the liver in glutaric aciduria type 1?},
journal = {Journal of Inherited Metabolic Disease},
year = {2023},
doi = {10.1002/jimd.12623}
}
EUVIMED